Randomized Controlled Pilot Study of Highly Active Anti-Retroviral Therapy for Patients With Primary Biliary Cirrhosis
Latest Information Update: 25 Nov 2024
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Lopinavir/ritonavir (Primary)
- Indications Biliary cirrhosis
- Focus Pharmacodynamics
- Acronyms HAART
Most Recent Events
- 21 Nov 2024 Status changed to discontinued.
- 01 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Dec 2014 Planned End Date changed from 1 Sep 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.